Adocia SA

    Jurisdiction
    France
    LEI
    969500ZL79KYH9PTYP78
    ISIN
    FR0011184241 (ADOC.PA)
    Sectors
    1. Healthcare
    2. Biotechnology

    Scores

    InsiderPie Expert Score
    trending_flat 50 / 100
    Even with peer group:
    50 / 100
    Fair value (Benjamin Graham formula)
    N/A
    Fundamental strength relative to industry (Mohanram G-Value)
    1 / 7

    Profile

    Adocia SA, a clinical-stage biotechnology company, researches and develops formulations of pre-approved therapeutic proteins and peptides for the treatment of diabetes and other metabolic diseases. Read full profile

    Stock price

    Stock price loading... No stock price available Stock price provided by Lang & Schwarz Steigende Zinsen und niedrigere Bewertungen für Wachstumsaktien im Allgemeinen Eine Gewinnwarnung beim Konkurrenten Adyen signalisiert eine Abkühlung des europäischen Markts für Zahlungsdienstleistungen. Eine Gewinnwarnung von Wordline SA triggert einen massiven Kursverlust.

    Configure chart

    Adjust colors to be more accessible for red-green-colorblind users.
    Scale
    Moving average Display a moving average line on the chart.

    Fundamentals

    Net revenue
    €11.47M
    Gross margin
    -158.6%
    EBIT
    -€18.12M
    EBIT margin
    -158.0%
    Net income
    -€30.48M
    Net margin
    -265.8%

    Statement period: - (published )

    Dividends

    No dividend payouts

    Add to watchlist

    Notifications